Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05299749 · ClinicalTrials.gov registry record · NA
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
A NA study of Schizophrenia and Treatment-resistant Schizophrenia, sponsored by Boston VA Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT05299749 is a NA study of Schizophrenia and Treatment-resistant Schizophrenia that is actively recruiting participants, run by Boston VA Research Institute. The registered enrollment target is 104 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05299749, a NA study of Schizophrenia and Treatment-resistant Schizophrenia, is actively recruiting participants, sponsored by Boston VA Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
Neurofeedback intervention aimed to regulate the superior temporal gyrus (STG) activation and default mode network (DMN) connectivity as well as to reduce the auditory hallucinations (AH) schizophrenia patients with medication resistant AH.
Conditions Studied
Interventions
- OTHER stg-rt-fMRI-Neurofeeback
- OTHER sham-rt-fMRI-Neurofeedback
Study Locations (1)
Massachusetts
- Boston VA Healthcare System, Brockton - Brockton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05299749
The ClinicalTrials.gov registry entry for NCT05299749 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (53% lower). The listed sponsor is Boston VA Research Institute, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which stg-rt-fMRI-Neurofeeback is the first listed.
NCT05299749 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05299749 about?
NCT05299749 is a clinical study titled "Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations". Neurofeedback intervention aimed to regulate the superior temporal gyrus (STG) activation and default mode network (DMN) connectivity as well as to reduce the auditory hallucinations (AH) schizophrenia patients with medication resistant AH.
What is the current status of trial NCT05299749?
This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2022-03-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05299749 study?
This clinical trial studies the following conditions: Schizophrenia, Treatment-resistant Schizophrenia, Auditory Hallucination.
What interventions are being tested in trial NCT05299749?
The interventions under investigation include: stg-rt-fMRI-Neurofeeback (OTHER), sham-rt-fMRI-Neurofeedback (OTHER).
Who is sponsoring clinical trial NCT05299749?
This trial is sponsored by Boston VA Research Institute, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05299749 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.